CVS Health is developing a new tobacco-free pharmacy network and will charge clients who fill prescriptions at stores that sell tobacco.» Read More
Oracle has sued Oregon over its health insurance exchange, saying officials are using the company's software despite disputed bills.
Twenty-nine state attorneys general have urged the FDA to impose stricter regulations on e-cigarettes,similar to those of traditional cigarettes.
Is the world ready for genetically modified babies? Here's how close we really are, explains Jessica Cussins of the Center for Genetics and Society.
Don't believe the hype that insurance companies are getting squeezed on Obamacare. That's the message from Ezekiel Emanuel, one of the law's architects.
Tekmira Pharmaceutical's stocks have soared since the U.S. Food and Drug Administration cleared its experimental Ebola drug for human use.
The outbreak of the Ebola virus in West Africa is an ‘extraordinary event’ and a public health risk to other countries, WHO has warned.
Pfizer is facing a mounting wave of lawsuits by women who allege that the company knew about possible serious side effects of its drug Lipitor.
Looking to trade on the Ebola scare? Ex-trader Turney Duff offers up what he'd do—and a word of caution.
It's unlikely but not outside the realm of possibility that those infected with Ebola will come to the U.S., the CDC's Beth Bell said.
HealthCare.gov won't disclose some key details of Obamacare, including how many people have paid, insurer market share and proposed 2015 prices.
The Centers for Disease Control and Prevention ramped up its response to the expanding Ebola outbreak.
Buried deep in the government's new tobacco regulations is a calculation that public health experts see as poisonous: the happiness quotient.
Mount Sinai hospital in New York has confirmed that a patient who was being tested for the deadly Ebola virus has been cleared for the disease by the CDC.
Delta Air Line's CEO said the airline's priority is making sure its operations are safe for passengers and crew members.
Diseases like Ebola will affect us in this era of global health care, the Cleveland Clinic CEO said.
An experimental treatment for the Ebola virus is rooted in a therapy devised more than 100 years ago—serum. NBC News reports.
A new Gallup poll shows that Obamacare is cutting the uninsured rate quickest in states with close Senate races. Fiscal Times reports.
The arrival of two U.S. Ebola patients and the testing of ill patients that recently traveled from West Africa have created fears. But are they genuine?
Mount Sinai Health System CEO Dr. Kenneth Davis told CNBC that a sick man who was recently in West Africa is "extremely unlikely" have to the deadly virus.
Terminally ill patients are increasingly seeking access experimental drugs outside clinical trials, but drug companies often decline these requests. A look at why.
Get the best of CNBC in your inbox